3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
1
Prostatic Neoplasms
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lung Neoplasms
1
Hematologic Diseases
1
Glioma
1
Fatigue
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Bone Neoplasms
1
Bone Marrow Diseases
1
Interventions
Specimen Handling
6
pembrolizumab
4
enfortumab vedotin
4
Magnetic Resonance Spectroscopy
4
Nivolumab
3
Gemcitabine
3
cabozantinib
2
avelumab
2
Ipilimumab
2
Immunoglobulin G
2
Disulfides
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
tremelimumab
1
tocilizumab
1
relatlimab
1
eribulin
1
erdafitinib
1
durvalumab
1
atezolizumab
1
Watchful Waiting
1
Standard of Care
1
Practice Guidelines as Topic
1
Plasmapheresis
1
Plasma Exchange
1
Observation
1
Lenalidomide
1
Doxorubicin
1
Cystoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ureteral Neoplasms
×
Quality of Life
×
90 days
×
Clear all
No trials found.